PARTICIPA

PARTICIPA

viernes, 29 de diciembre de 2017

Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices — NEJM

Ahora que hemos elaborado un circuito en nuestro departamento para revisar y cuidar estas pruebas en pacientes portadores de MP y DF aparte este articulo que resume y describe su evidencia en un numero significativo de pacientes.

http://www.nejm.org/doi/full/10.1056/NEJMoa1604267


Enviado desde mi iPhone

jueves, 28 de diciembre de 2017

Hypoglycemia in Hospice Patients With Type 2 Diabetes | Cardiology | JAMA Internal Medicine | The JAMA Network



El articulo trata de la necesidad de modificar objetivos control glucemia en pacientes terminales ó incluso de retirar el tratamiento en base a la alta frecuencia de hipoglucemias con el consiguiente sufrimiento de los pacientes.

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2665732


Enviado desde mi iPhone

miércoles, 13 de diciembre de 2017

Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines | BMJ Open



Enviado desde mi iPad

Resistencia antibióticos y atención primaria.



Enviado desde mi iPad

Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function Undergoing IVF | Endocrinology | JAMA | The JAMA Network



Enviado desde mi iPad

jueves, 7 de diciembre de 2017

Guia manejo Insuficiencia cardiaca de enfermería de Atención primaria

https://www.picuida.es/wp-content/uploads/2017/12/guiainsuficiencia.pdf

Semaglutide Approved for Type 2 Diabetes

https://www.jwatch.org/fw113608/2017/12/07/semaglutide-approved-type-2-diabetes


Enviado desde mi iPhone

Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk | Cochrane

http://www.cochrane.org/CD003054/ENDOC_diet-physical-activity-or-both-prevention-or-delay-type-2-diabetes-mellitus-and-its-associated


Enviado desde mi iPhone

Avances en gestión clínica: El síndrome de post-hospitalización

Aunque hay cosas que no me gustan subyace oculto el tema ruta asistencial o no??
http://gestionclinicavarela.blogspot.com/2017/12/el-sindrome-de-post-hospitalizacion.html


Enviado desde mi iPhone

Por qué Albert Einstein no podría ser profesor en España - elasterisco.es - Opiniones y notas al margen

http://www.elasterisco.es/albert-einstein/


Enviado desde mi iPhone

domingo, 3 de diciembre de 2017

Eurosurveillance | Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017

Baja eficacia de la vacuna antigripal en hemisferio sur.

Eurosurveillance | Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017

The ongoing Australian 2017 influenza season was so far characterised by record-high laboratory-confirmed influenza notifications [], high consultation rates, high hospitalisation and mortality rates, particularly in New South Wales [], large numbers of institutional outbreaks [] and media attention. The southern hemisphere influenza vaccine used in Australia for this season was a quadrivalent formulation comprised of an A/Michigan/45/2015 (H1N1)pdm09-like virus, an A/Hong Kong/4801/2014 (H3N2)-like virus, a B/Brisbane/60/2008-like virus (of the B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (of the B/Yamagata/16/88 lineage) [,]. This same vaccine composition is being used in the upcoming northern hemisphere for the 2017/18 influenza season []. Here we report interim influenza vaccine effectiveness estimates for 2017 in Australia, using sentinel surveillance data.
The Australian Sentinel Practices Research Network (ASPREN) and the Victorian Sentinel Practice Influenza Network (VicSPIN) constitute Australia's two sentinel influenza general practice (GP) networks. VicSPIN operates in the state of Victoria, while ASPREN operates nationally. Both surveillance systems use similar data collection methods [,], with the key difference that the VicSPIN surveillance period is limited to weeks 18 to 43 (1 May 1– 29 October), timed to start roughly 2 weeks after vaccination campaigns in mid-April. Briefly, sentinel GPs submit weekly reports of the number of patients seen with influenza-like illness (ILI), defined as fever/history of fever, cough and fatigue, and the total number of patients. Nose/throat swabs are collected from a subset of patients with demographic data, date of ILI onset, vaccination status (self-reported or medical record) and indications for vaccination, such as belonging to an influenza risk group. Swabs are tested by RT-PCR and positive samples are referred to the World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza in Melbourne, for antigenic characterisation by haemagglutination inhibition assay (HAI) [] or focus reduction assay (FRA) [] and genetic sequencing, as described previously []. All data were managed and analysed using R version 3.4.1.
ILI data from ASPREN for 2017 and 2012 to 2016 (averaged) are plotted in and indicate consultation rates were higher in 2017 than in the previous 5 years. For the study period from 1 May 2017 to 24 September 2017, i.e. weeks 18–38, the 262 ASPREN GPs and 88 VicSPIN GPs conducted 493,961 consultations, of which 5,678 (1.1%) met the ILI case definition and swabs were collected from 2,465 (43%) of them. Influenza cases were detected in every week of the study period and peaked in week 34 (21–27 August, n = 235). Percentage of positive samples peaked in week 32 (7–13 August) with 58%.

Figure 1
Sentinel general practice (GP) surveillance dataa, (A) ILI consultation rates, (B) laboratory detections of influenza patients by week and type/subtype, Australia, 2 January–24 September 2017


manuel sanchez molla compartió un enlace: Ten lessons for redesigning care pathways | The Health Foundation



Enviado desde mi iPad